China-based pharmaceutical companies have experienced noteworthy success in achieving patient recruitment milestones, even in the face of the global pandemic. For example, VISEN Pharmaceuticals, a China-based pharmaceutical company, was successfully able to recruit pediatric patients for their innovative hormonal therapeutic to treat children with growth hormone deficiency (GHD) (1). Although many countries are facing challenges in clinical trials logistics, companies and affiliates in China have demonstrated due perseverance, especially in the case of patient recruitment (1).
In addition, large CROs such as Covance are able to achieve patient recruitment which further indicates that China is a favorable country to conduct trials (2). For example, China has a pronounced need for prevention of chemotherapy-induced neutropenia (CIN) among cancer patients and Covance was responsible for patient recruitment (2). Without fail, Covance teams accordingly identified sites in China for their drug Plinabulin, which is a therapeutic from the American pharmaceutical company named BeyondSpring (2).
Pharmaceutical companies often seek both U.S. FDA approval and China NMPA approval as a part of their projected timelines, which shows that concurrent approval goals are becoming increasingly standardized in the industry. For example, a French ophthalmology company called Nicox is seeking both American and Chinese regulatory approvals for multiple glaucoma drug candidates (3). Nicox operations achieved their milestone patient recruitment rates, including those among trial sites in China, despite logistical challenges related to the pandemic (3).
Source Links for Patient Recruitment Perspective
CR Medicon (https://en.crmedicon.com) provides innovative pharma and biotech companies with comprehensive clinical development services, including drug registration, medical affairs, clinical operations, data management & statistical analysis, and biological sample analysis. We are China’s most well-known clinical CRO partner, for both domestic and overseas companies. CR Medicon team consists more than 500 full-time employees with clinical sites in both USA and China. Contact us at +1 (732) 624-9052 or email email@example.com.